Navigation Links
3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results
Date:8/15/2011

RMB2.37 (US$0.35) for the same period in 2010. Net margin for the first half of 2011 was 20.7%, a 5.1% decrease over net margin of 25.8% for the same period in 2010.

Conference Call3SBio's senior management will host a conference call on Tuesday, August 16, 2011 at 5:00am (US Pacific) / 8:00am (US Eastern) / 8:00pm (Beijing) to discuss its unaudited second quarter and first half 2011 results and recent business activity. The conference call may be accessed using the dial-in numbers below:Conference ID:83204042Local dial-in:China landline:

800-819-0121China mobile:

400-620-8038Hong Kong:

852-2475-0994United States:

718-354-1231 International toll-free dial-in:Hong Kong:

800930346United States:

1-866-519-4004United Kingdom:

080-8234-6646International toll dial-in:65 6723 9381Replay- Conference ID:83204042A telephone replay will be available two hours after the call until August 23, 2011 at:

International:

61-2-8235-5000United States:

1-866-214-5335WebcastA live webcast of the conference will be available on the investor relations section of 3SBio's website at www.3sbio.com and at http://tinyurl.com/3sbio2Q11.

A replay of the webcast will be available within one hour after the conclusion of the call.

Statement Regarding Unaudited Financial InformationThe unaudited financial information set forth above is preliminary and subject to adjustments and modifications. The audited financial statements and related notes are to be included in the Company's annual report on Form 20-F for the year ending December 31, 2011. Adjustments and modifications to the financial statements may be identified during the course of the audit work, which could result in significant differences from this preliminary unaudited financial information.

Currency Convenience TranslationFor t
'/>"/>

SOURCE 3SBio Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. 3SBio Inc. Schedules Unaudited Second Quarter 2011 Results
2. 3SBio Inc. Announces SFDA Approval of High-Dose EPIAO
3. 3SBio Announces Conversion of Isotechnika Debenture
4. 3SBio Inc. Schedules Third Quarter 2010 Unaudited Financial Results
5. 3SBio Announces Partial Conversion of Isotechnika Debenture
6. 3SBio Announces Investor Conference Schedule
7. 3SBio and Isotechnika Pharma Announce Strategic Partnership to Develop and Commercialize Voclosporin in China
8. 3SBio Inc. Announces Results of Annual General Meeting
9. NewCardio Announces Financial Results for Its 2011 Second Quarter
10. Dehaier Medical Announces Record Second Quarter 2011 Financial Results
11. Emdeon Announces Support for Electronic Prescribing of Controlled Substances Using the DEA-Allowed Quicker-to-Market Approach
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... BUFFALO, N.Y. , July 24, 2014  Kinex ... US FDA for the Company,s KX2-391 Ointment for the ... keratosis. This is the Company,s third IND to be ... months. KX2-391 is a synthetic, orally active ... and tubulin polymerization. KX2-391 promotes the induction of p53, ...
(Date:7/24/2014)... July 24, 2014 Research and Markets ... Monitoring Market by Product, Component, Application and Geography - ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... expected to witness a moderate growth as the markets ... have almost reached the saturation levels. The demand is ...
(Date:7/24/2014)... July 24, 2014 /PRNewswire-iReach/ -- "North America Orthopedic Braces ... data on the North America Orthopedic Braces and Supports ... dollars, and volume (in units) and average price data ... Knee Braces and Supports , Ankle Braces and ... Upper Extremities Braces and Supports. ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 2Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 3Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA) 4Machine Health Monitoring (Vibration Monitoring, Thermography, Ultrasound Emission, Lubricating Oil Analysis, Corrosion Monitoring, Motor Current Signature Analysis) Market - Forecast to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 2North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 3North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 4North America Orthopedic Braces and Supports Market (Knee, Ankle & Spinal Braces) to 2020 5
... Nov. 7, 2011 Inovio Pharmaceuticals, Inc. (NYSE AMEX: ... 30, 2011. Total revenue was $2.6 million and $8.2 ... compared to $1.3 million and $3.8 million for the same periods ... nine months ended September 30, 2011, were $9.0 million and $24.0 ...
... CHICAGO, Nov. 7, 2011 UCB today announced findings ... rates to Cimzia ® (certolizumab pegol) plus methotrexate ... effect on structural joint damage in patients with moderate ... responses were found by both RAPID3 (Routine Assessment of ...
Cached Medicine Technology:Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 2Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 3Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 4Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 5Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 6Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 7Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 8Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results 9New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 2New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 3New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 4New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 5New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 6New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 7New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 8New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 9New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 10New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 11New RAPID 1 Post-Hoc Analysis Showed Early Response to Cimzia® (certolizumab pegol) at Week 12 was Predictive of Week 52 Response 12
(Date:7/24/2014)... may have found a way to delay or even ... neurons with the anti-aging protein Klotho can prevent neuron ... and glutamate. These findings currently appear in the ... is the most frequent age-related dementia affecting 5.4 million ... older and more than 40 percent of people over ...
(Date:7/24/2014)... -- Drinking caffeine may worsen the hot flashes and ... they go through menopause, new survey data suggests. ... limiting caffeine intake may be useful for those postmenopausal ... said researcher Dr. Stephanie Faubion, director of the Women,s ... But caffeine -- a stimulant found in coffee ...
(Date:7/24/2014)... Bonheur Children,s Hospital and the University of Tennessee Health ... a new drug shown to safely reduce the viral ... infected with respiratory syncytial virus (RSV). RSV is the ... young children in the United States and worldwide. ... Disease Specialist John DeVincenzo, MD. DeVincenzo,s Le Bonheur lab ...
(Date:7/24/2014)... 2014 As the age of marriage ... freezing as a way to ensure future family building ... with advancing reproductive age. Vitrification technology, a fast freeze ... medical technology that allows a woman to have multiple ... years, which are then stored for future use. When ...
(Date:7/24/2014)... 24, 2014 In a recent report by ... officially put an end to criminal penalties associated with possession ... era for marijuana reform in Washington DC, giving it one ... law replaces criminal penalties for possession of one ounce of ... the possession of more than an ounce of marijuana remain ...
Breaking Medicine News(10 mins):Health News:BU researchers discover that Klotho is neuroprotective against Alzheimer's disease 2Health News:Is Coffee Aggravating Your Hot Flashes? 2Health News:RSV research breakthrough to help infected children 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 2Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 3Health News:Expanded Financial Options for Women Interested in Proactive Egg Freezing at Shady Grove Fertility 4Health News:Washington D.C. Decriminalizes Marijuana 2
... for more careful screening for these patients, researcher says ... with metabolic syndrome have a 75 percent higher risk ... new study suggests. , "Metabolic syndrome is a conglomeration ... a worse prognosis for certain illnesses, including a number ...
... a protein that plays matchmaker between two key types ... them to interact in a way that is crucial ... finding may also explain why some individuals who have ... proteincalled SAPsuffer from lethal infections with a common virus ...
... The Johns Hopkins University School,of Medicine is ... Cancer Strategies: From Biomarkers to Treatment,Selection," to present ... in,breast cancer treatment., In recent years, advancements ... chemotherapeutic and biologic treatment combinations that are,increasingly tailored ...
... Molecular CT adds metabolic information from PET to traditional ... for maximized workflow ... and quick return on investment, MUNICH, Germany, Oct. ... a new concept in,integrated imaging that provides a premium ...
... This may sound like,science fiction, but it is truly ... become the first U.S. doctor,licensed to provide TA-65 to ... Beach, Florida., This is a revolutionary technology that ... DNA. They are located at the ends of all ...
... Oct. 9 After a thorough review of ... (VDSS),announced that it has selected Policy Studies Inc. ... the Chesapeake and Hampton districts.,PSI is a leading ... The contract is valued at approximately $7 million ...
Cached Medicine News:Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 2Health News:Metabolic Syndrome Raises Colon Cancer Risk 75% 3Health News:NIH scientists discover crucial control in long-lasting immunity 2Health News:NIH scientists discover crucial control in long-lasting immunity 3Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 2Health News:Science Fiction Has Become Reality with Remarkable Anti-Aging Treatment Breakthrough - Turning Back the Biological Clock in Aging 3Health News:PSI Selected to Operate Virginia's Child Support Program in Chesapeake and Hampton 2
Used for measuring rectal pressure during urodynamic studies. All-silicone construction provides maximum softness and biocompatibility for enhanced patient comfort. Supplied sterile in peel-open pack...
... for cystometry and urethral pressure profilometry. ... faster filling of the bladder and ... lumen catheter construction allows the bladder ... performed. Triple lumen catheter construction allows ...
... with AMI symptoms and time is ... rapid, reliable and accurate solution for ... enhancement techniques, state-of-the-art fluorescence analysis, and ... delivers highly sensitive results without compromising ...
... Capillary Blood Collection Tubes are 100% plastic ... wide range of applications, the Capillary Collection ... attached cap and a micro tube.,The capillary ... blood into the micro tube thereby eliminating ...
Medicine Products: